Targeting TNFR2-A key regulator of the tumor immunosuppressive microenvironment

被引：0
|
作者：
Raue, A. [1 ]
Fulton, R. [1 ]
Sampson, J. [1 ]
Camblin, A. [1 ]
Richards, J. [1 ]
Jiao, Y. [1 ]
Xu, L. [1 ]
Wong, C. [1 ]
Koshkaryev, A. [1 ]
Paragas, V. [1 ]
Luus, L. [1 ]
Ghassemifar, S. [1 ]
Razlog, M. [1 ]
Dugast, A. S. [1 ]
Depis, F. [1 ]
Muda, M. [1 ]
Tam, E. [1 ]
Drummond, D. [1 ]
机构：
[1] Merrimack Pharmaceut Inc, Res, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
231 (PB-08
引用
收藏
页码：E81 / E81
页数：1
相关论文
共 50 条
  • [31] Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer
    Mussa, Ali
    Ismail, Nor Hayati
    Hamid, Mahasin
    Al-Hatamleh, Mohammad A. I.
    Bragoli, Anthony
    Hajissa, Khalid
    Mokhtar, Noor Fatmawati
    Mohamud, Rohimah
    Uskokovic, Vuk
    Hassan, Rosline
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [32] EMT produces an immunosuppressive tumor microenvironment
    Chen, Limo
    Lou, Yanyan
    Wistuba, Ignacio
    Ullrich, Stephen
    Qin, Xiao-Feng
    Byers, Lauren
    Heymach, John
    Gibbons, Don
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [33] MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2
    Jiang, Mengmeng
    Yang, Yang
    Niu, Liling
    Li, Ping
    Chen, Yibo
    Liao, Ping
    Wang, Yifei
    Zheng, Jingbin
    Chen, Fengyang
    He, Huanhuan
    Li, Hui
    Chen, Xin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (11)
  • [34] CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study
    Suresh Singh Yadav
    Shyam Babu Prasad
    Chandra Bhushan Prasad
    Lakshmi Kant Pandey
    Satyajit Pradhan
    Sunita Singh
    Gopeshwar Narayan
    Clinical & Experimental Metastasis, 2016, 33 : 431 - 439
  • [35] CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study
    Yadav, Suresh Singh
    Prasad, Shyam Babu
    Prasad, Chandra Bhushan
    Pandey, Lakshmi Kant
    Pradhan, Satyajit
    Singh, Sunita
    Narayan, Gopeshwar
    CLINICAL & EXPERIMENTAL METASTASIS, 2016, 33 (05) : 431 - 439
  • [36] Targeting polymorphonuclear myeloid-derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
    Li, Shiqi
    Long, Xinghua
    MEDCOMM, 2024, 5 (07):
  • [37] MESOTHELIN (MSLN) TARGETING ALLOGENEIC CAR T CELLS ENGINEERED TO OVERCOME TUMOR IMMUNOSUPPRESSIVE MICROENVIRONMENT
    Schiffer-Mannioui, Cecile
    Leduc, Sophie
    Chion-Sotinel, Isabelle
    le Clerre, Diane
    Guyot, Valerie
    Rotondi, Marco
    Galetto, Roman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A151 - A151
  • [38] Improving the efficacy of immunotherapy for colorectal cancer: Targeting tumor microenvironment-associated immunosuppressive cells
    Zou, Daoyang
    Xin, Xi
    Xu, Yunxian
    Xu, Huangzhen
    Huang, Linyan
    Xu, Tianwen
    HELIYON, 2024, 10 (16)
  • [39] CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma
    Lewinsky, Hadas
    Gunes, Emine G.
    David, Keren
    Radomir, Lihi
    Kramer, Matthias P.
    Pellegrino, Bianca
    Perpinial, Michal
    Chen, Jing
    He, Ting-fang
    Mansour, Anthony G.
    Teng, Kun-Yu
    Bhattacharya, Supriyo
    Caserta, Enrico
    Troadec, Estelle
    Lee, Peter
    Feng, Mingye
    Keats, Jonathan
    Krishnan, Amrita
    Rosenzweig, Michael
    Yu, Jianhua
    Caligiuri, Michael A.
    Cohen, Yosef
    Shevetz, Olga
    Becker-Herman, Shirly
    Pichiorri, Flavia
    Rosen, Steven
    Shachar, Idit
    JCI INSIGHT, 2021, 6 (04)
  • [40] Nuclear EGFR as a regulator of the tumor microenvironment
    Escoto, Angelica
    CANCER RESEARCH, 2024, 84 (03)
12345